Hye-Young Min Selected Research

7- O- (2,6- Dideoxy- 2- fluoro- alpha- talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride

12/2005

Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hye-Young Min Research Topics

Disease

52	Neoplasms (Cancer) 04/2022 - 06/2003
19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 12/2011
16	Lung Neoplasms (Lung Cancer) 04/2022 - 10/2004
14	Carcinogenesis 04/2022 - 01/2002
7	Neoplasm Metastasis (Metastasis) 03/2021 - 12/2005
7	Inflammation (Inflammations) 05/2020 - 01/2002
6	Colonic Neoplasms (Colon Cancer) 10/2015 - 04/2003
5	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2009
5	Fibrosarcoma 08/2012 - 11/2005
4	Squamous Cell Carcinoma of Head and Neck 03/2021 - 12/2011
4	Body Weight (Weight, Body) 05/2020 - 08/2012
2	Pulmonary Emphysema 05/2020 - 05/2020
2	Emphysema 05/2020 - 05/2020
2	Hematologic Neoplasms (Hematological Malignancy) 03/2017 - 06/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2021
1	Lewis Lung Carcinoma 01/2021
1	Residual Neoplasm 07/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2008
6	Insulin-Like PeptidesIBA 03/2021 - 05/2013
4	CarcinogensIBA 04/2022 - 01/2011
4	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2021 - 06/2015
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2012 - 12/2005
4	Matrix Metalloproteinases (MMPs)IBA 08/2012 - 12/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 03/2012
3	deguelinIBA 01/2022 - 05/2013
3	Biological ProductsIBA 01/2021 - 05/2006
3	Antineoplastic Agents (Antineoplastics)IBA 04/2020 - 12/2005
3	StilbenesIBA 08/2012 - 10/2004
3	AlkaloidsIBA 03/2012 - 11/2005
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2011 - 01/2002
3	Messenger RNA (mRNA)IBA 05/2006 - 12/2005
3	ZincIBA 05/2006 - 12/2005
3	Peptide Hydrolases (Proteases)FDA Link 05/2006 - 12/2005
2	CateninsIBA 04/2022 - 08/2012
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2020
2	Insulin-Like Growth Factor Binding Protein 3IBA 03/2021 - 11/2012
2	Phosphotransferases (Kinase)IBA 01/2021 - 10/2016
2	evodiamineIBA 01/2021 - 03/2014
2	Coloring Agents (Dyes)IBA 01/2021 - 07/2020
2	Activating Transcription Factor 6IBA 07/2020 - 01/2020
2	Pancreatic Elastase (Elastase)IBA 05/2020 - 05/2020
2	Adenosine A3 ReceptorIBA 05/2020 - 05/2020
2	CytokinesIBA 05/2020 - 01/2020
2	gracillinIBA 04/2020 - 10/2019
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 08/2015
2	IntegrinsIBA 01/2020 - 10/2013
2	falcarinolIBA 01/2018 - 01/2018
2	Vorinostat FDA Link 03/2017 - 06/2015
2	Histone Deacetylases (Histone Deacetylase)IBA 03/2017 - 06/2015
2	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 11/2016 - 09/2016
2	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 10/2016 - 09/2016
2	Histone Deacetylase InhibitorsIBA 06/2015 - 11/2012
2	cixutumumabIBA 10/2013 - 12/2011
2	pinosylvinIBA 08/2012 - 12/2004
2	antofineIBA 03/2012 - 11/2010
2	phenanthroindolizidineIBA 03/2012 - 11/2010
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2011 - 10/2004
2	EnzymesIBA 01/2011 - 10/2007
2	Estrogen ReceptorsIBA 02/2010 - 05/2009
2	LignansIBA 05/2009 - 01/2008
2	Ether (Diethyl Ether)IBA 09/2008 - 03/2005
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2008 - 09/2005
2	Adenosine (Adenocard)FDA LinkGeneric 06/2008 - 09/2005
2	thio-Cl-IB-MECAIBA 06/2008 - 09/2005
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2007 - 06/2003
2	ProstaglandinsIBA 10/2007 - 01/2002
2	Tissue Inhibitor of Metalloproteinase-2IBA 05/2006 - 12/2005
2	indoleIBA 12/2005 - 10/2004
2	Tissue Inhibitor of MetalloproteinasesIBA 12/2005 - 12/2005
2	Nitric Oxide Synthase (NO Synthase)IBA 04/2005 - 01/2002
2	ResveratrolIBA 10/2004 - 04/2003
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	LigandsIBA 04/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2022
1	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 03/2021
1	VimentinIBA 03/2021
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 07/2020
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 07/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2020
1	2- chloro- N(6)- (3- iodobenzyl)- 5'- N- methylcarbamoyl- 4'- thioadenosineIBA 05/2020
1	PPAR gammaIBA 05/2020
1	LJ-2698IBA 05/2020
1	Collagen Type I (Type I Collagen)IBA 01/2020
1	papuamineIBA 01/2020
1	Superoxides (Superoxide)IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	LipidsIBA 01/2018
1	erybraedin AIBA 01/2018
1	pyrimidineIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	MethyltransferasesIBA 03/2017

Therapy/Procedure

10	Therapeutics 01/2021 - 05/2013
7	Drug Therapy (Chemotherapy) 02/2021 - 03/2012
1	Molecular Targeted Therapy 01/2018
1	Immunotherapy 01/2018